Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2019ex32-1_hoththera.htm |
| EX-31.2 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2019ex31-2_hoththera.htm |
| EX-31.1 - CERTIFICATION - Hoth Therapeutics, Inc. | f10k2019ex31-1_hoththera.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Hoth Therapeutics, Inc. | f10k2019ex21-1_hoththera.htm |
| EX-10.22 - LICENSE AGREEMENT WITH NORTH CAROLINA STATE UNIVERSITY DATED NOVEMBER 20, 2019 - Hoth Therapeutics, Inc. | f10k2019ex10-22_hoththerap.htm |
| EX-10.9 - RENEWAL AGREEMENT WITH REGUS DATED MAY 2, 2019 - Hoth Therapeutics, Inc. | f10k2019ex10-9_hoththera.htm |
| 10-K - ANNUAL REPORT - Hoth Therapeutics, Inc. | f10k2019_hoththerapeutics.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference of our report dated March 2, 2020, relating to the consolidated financial statements of Hoth Therapeutics, Inc. as of and for the years ended December 31, 2019 and 2018, included in this Annual Report on Form 10-K into the Company’s previously filed Registration Statement on Form S-1 (File No. 333-233563).
| /s/ WithumSmith+Brown, PC | |
| New York, New York | |
| March 2, 2020 |